Day By Day - FRESENIUS MEDICAL CARE AG CO KGAA (FME) Analyse court terme - FRESENIUS MEDICAL CARE AG CO KGAA : La rÃ©sistance est atteinte

Report

Day By Day

Jérôme VINERIER

EUR 104.42 For Business Accounts Only

Analyse court terme - FRESENIUS MEDICAL CARE AG & CO KGAA : La rÃ©sistance est atteinte

La tendance est toujours neutre. Il faut enfoncer le creux Ã 82,05 â‚¬ pour que la tendance devienne nÃ©gative avec une invalidation au-dessus de 88,50 â‚¬.

Arguments :
- La rÃ©sistance est atteinte, un signe de faiblesse nous permettrait de changer notre avis.
- La moyenne mobile sert de support.

22/02/2018 1 FR

Underlying

FRESENIUS MEDICAL CARE AG & CO KGAA

See profile

Provider

Day By Day

DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

See profile

Analysts

Jérôme VINERIER

Other Reports on these Companies

Independent Investment Research

Monthly LMI Update Independent Investment Research

Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked. This compares to the total dividends of 5 cents per share in FY20. The Board has confirmed that, in...

August 6, 2021 August 6, 2021 10 EN

MarketLine

Sanofi Genzyme - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Sanofi Genzyme Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Sanofi Genzyme since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key High...

EUR 300.51

October 29, 2020 October 29, 2020 252 EN

Day By Day

Short term view - FRESENIUS MEDICAL CARE AG & CO KGAA : The resistance has been reached, it causes the fall.

The trend is still neutral but within that interval prices could head towards the bottom of the range.Arguments :- The support is close.- The resistance has been reached, it causes the fall.- The moving average is capping prices.

EUR 97.56

April 24, 2018 April 24, 2018 1 EN

Short term view - GBP-CHF : The major resistance is close.

The trend remains neutral. Prices will have to break above the peak at CHF 1.3104 for the trend to be positive again with an invalidation level below CHF 1.2740.Arguments :- The major resistance is close.- The moving average is capping prices.

EUR 103.03

November 2, 2018 November 2, 2018 1 EN

Valérie GASTALDY

Valérie GASTALDY

La tendance est toujours neutre. Il faut franchir le sommet Ã 1,3104 CHF pour que la tendance devienne positive avec une invalidation sous 1,2740 CHF.Arguments :- La rÃ©sistance majeure est proche.- La moyenne mobile sert de rÃ©sistance.

EUR 103.03

November 2, 2018 November 2, 2018 1 FR

Valérie GASTALDY

Valérie GASTALDY

Analyse court terme - GBP-USD : Pull-back

La tendance est momentanÃ©ment interrompue par une correction sur l'horizon de temps infÃ©rieur, mais les prix restent en-dessous du seuil d'invalidation Ã 1,3210 $. Elle peut donc rependre Ã tout moment vers l'objectif Ã 1,2600 $.Arguments :- Les cours font un pull-back sur la rÃ©sistance majeure (ancien support), la baisse reprendra ensuite.- La moyenne mobile, baissiÃ¨re, confirme notre avis.

EUR 103.03

November 2, 2018 November 2, 2018 1 FR

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Analyse court terme - FRESENIUS MEDICAL CARE AG & CO KGAA : La rÃ©sistance est atteinte

Monthly LMI Update Independent Investment Research

Sanofi Genzyme - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Short term view - FRESENIUS MEDICAL CARE AG & CO KGAA : The resistance has been reached, it causes the fall.

Short term view - GBP-CHF : The major resistance is close.

Analyse court terme - GBP-CHF : La rÃ©sistance majeure est proche.

Analyse court terme - GBP-USD : Pull-back

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe